sudden cardiac death

  1. SNT Gatchaman

    Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for AF and sudden cardiac death, 2023

    Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors Fiedler, Lukas; Motloch, Lukas J.; Dieplinger, Anna-Maria; Jirak, Peter...
    • SNT Gatchaman
    • Thread
    • anticoagulation arrhythmia cardiac cardiovascular complications coagulation coagulopathy long covid sudden cardiac death thrombosis
    • Replies: 2
    • Forum: Long Covid research
Back
Top Bottom